beyond selenate . . . beyond selenomethionine . . . beyond whole selenized yeast . . .

page 4

PAGE 1 | PAGE 2 | PAGE 3 | PAGE 4 - REFERENCES

continued from page 3

References

1. Shamberger RJ, Frost DV. Possible protective effect of selenium against human cancer. Can Med Assoc J. 1969 Apr 12;100(14):682.
2. Nomura AM, Lee J, Stemmermann GN, Combs GF Jr. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):883-7.
3. Combs GF Jr, Gray WP. Chemopreventive agents: selenium. Pharmacol Ther. 1998
   Sep;79(3):179-92.
4. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA. 1996 Dec 25;276(24):1957-63.
5. Clark LC, Dalkin B, Krongrad A, Combs GF Jr, Turnbull BW, Slate EH, Witherington R, Herlong JH, Janosko E, Carpenter D, Borosso C, Falk S, Rounder J. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol. 1998 May;81(5):730-4.
6. Thomson CD, Rea HM, Doesburg VM, Robinson MF. Selenium concentrations and glutathione peroxidase activities in whole blood of New Zealand residents. Br J Nutr. 1977 May;37(3):457-60.
7. Whanger PD, Beilstein MA, Thomson CD, Robinson MF, Howe M. Blood selenium and glutathione peroxidase activity of populations in New Zealand, Oregon, and South Dakota. FASEB J. 1988 Nov;2(14):2996-3002.
8. Yang GQ, Zhu LZ, Liu SJ, Gu LZ, Qian PC, Huang JH, Lu MD. Human selenium requirements in China. In Combs GF Jr, Spallholz JE, Levander OA, Oldfield JE (eds). Selenium in Biology and Medicine. 1987; Van Nostrand Reinhold, New York:589-607.
9. Duffield AJ, Thomson CD, Hill KE,Williams S. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr. 1999 Nov;70(5):896-903.
10. Ganther H, Ip C. Thioredoxin reductase activity in rat liver is not affected by supranutritional levels of monomethylated selenium in vivo and is inhibited only by high levels of selenium in vitro. J Nutr. 2001 Feb;131(2):301-4.
11. Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention:
    complexities with thioredoxin reductase. Carcinogenesis. 1999 Sep;20(9):1657-66.
12. Berggren MM, Mangin JF, Gasdaka JR, Powis G. Effect of selenium on rat thioredoxin
    reductase activity: increase by supranutritional selenium and decrease by selenium deficiency. Biochem Pharmacol. 1999 Jan 15;57(2):187-93.
13. Davis CD, Feng Y, Hein DW, Finley JW. The chemical form of selenium influences 3,2’- dimethyl-4-aminobiphenyl-DNA adduct formation in rat colon. J Nutr. 1999 Jan;129(1):63-9.
14. Ip C, Hayes C. Tissue selenium levels in selenium-supplemented rats and their relevance in mammary cancer protection. Carcinogenesis. 1989 May;10(5):921-5.
15. Schrauzer GN. Nutritional selenium supplements: product types, quality, and safety. J Am Coll Nutr. 2001 Feb;20(1):1-4.
16. Feng Y, Finley JW, Davis CD, Becker WK, Fretland AJ, Hein DW. Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2’-dimethyl-4-aminobiphenyl. Toxicol Appl Pharmacol. 1999 May 15;157(1):36-42.
17. Ip C. Differential effect of dietary methionine on the biopotency of selenomethionine and selenite in cancer chemoprevention. J Natl Cancer Inst. 1988 Apr 20;80(4):258-62.
18. van ‘t Veer P, van der Wielen RP, Kok FJ, Hermus RJ, Sturmans F. Selenium in diet, blood, and toenails in relation to breast cancer: a case-control study. Am J Epidemiol. 1990 Jun;131(6):987-94.
19. Dong Y, Ganther HE, Stewart C, Ip C. Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res. 2002 Feb 1;62(3):708-14.
20. Wang Z, Jiang C, Ganther H, Lu J. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Cancer Res. 2001 Oct 1;61(19):7171-8.
21. Jiang C, Wang Z, Ganther H, Lu J. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res. 2001 Apr 1;61(7):3062-70.
22. Ip C, Ganther HE. Activity of methylated forms of selenium in cancer prevention. Cancer Res. 1990 Feb 15;50(4):1206-11.
23. Ip C, Ganther HE. Relationship between the chemical form of selenium and anticarcinogenic activity. In Wattenberg L, Lipkin M, Boone CW, Kelloff GJ. (eds). Cancer Chemoprevention. 1992; Boca Raton, FL: CRC Press, 479-88.
24. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr. 1998
    Nov;128(11):1845-54.
25. Ip C, Thompson HJ, Zhu Z, Ganther HE. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res. 2000 Jun 1;60(11):2882-6.
26. Medina D, Thompson H, Ganther H, Ip C. Se-methylselenocysteine: a new compound for chemoprevention of breast cancer. Nutr Cancer. 2001;40(1):12-7.
27. Lu J, Jiang C. Antiangiogenic activity of selenium in cancer chemoprevention: metabolitespecific effects. Nutr Cancer. 2001;40(1):64-73.
28. Jiang C, Ganther H, Lu J. Monomethyl selenium–specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation. Mol Carcinog. 2000 Dec;29(4):236-50.
29. Jiang C, Jiang W, Ip C, Ganther H, Lu J. Selenium-induced inhibition of angiogenesis in
    mammary cancer at chemopreventive levels of intake. Mol Carcinog. 1999 Dec;26(4):213-25.
30. Davis CD, Zeng H, Finley JW. Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J Nutr. 2002 Feb;132(2):307-9.
31. Finley JW, Davis CD. Selenium (Se) from high-selenium broccoli is utilized differently than selenite, selenate and selenomethionine, but is more effective in inhibiting colon carcinogenesis. Biofactors. 2001;14(1-4):191-6.
32. Finley JW, Davis CD, Feng Y. Selenium from high selenium broccoli protects rats from colon cancer. J Nutr. 2000 Sep;130(9):2384-9.
33. Finley JW, Ip C, Lisk DJ, Davis CD, Hintze KJ, Whanger PD. Cancer-protective properties of high-selenium broccoli. J Agric Food Chem. 2001 May;49(5):2679-83.
34. Zhu Z, Jiang W, Ganther HE, Thompson HJ. Mechanisms of cell cycle arrest by methylseleninic acid. Cancer Res. 2002 Jan 1;62(1):156-64.
35. Lu J, Kaeck M, Jiang C, Wilson AC, Thompson HJ. Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol. 1994 Apr 29;47(9):1531-5.
36. Lu J, Jiang C, Kaeck M, Ganther H, Vadhanavikit S, Ip C, Thompson H. Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol. 1995 Jul
    17;50(2):213-9.
37. Lu J, Pei H, Ip C, Lisk DJ, Ganther H, Thompson HJ. Effect on an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention.
    Carcinogenesis. 1996 Sep;17(9):1903-7.
38. Thompson HJ, Wilson A, Lu J, Singh M, Jiang C, Upadhyaya P, el-Bayoumy K, Ip C.
    Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis. 1994 Feb;15(2):183-6.
39. Wilson AC, Thompson HJ, Schedin PJ, Gibson NW, Ganther HE. Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage. Biochem Pharmacol. 1992 Mar 3;43(5):1137-41.
40. Unni E, Singh U, Ganther HE, Sinha R. Se-methylselenocysteine activates caspase-3 in
    mouse mammary epithelial tumor cells in vitro. Biofactors. 2001;14(1-4):169-77.
41. Sinha R, Unni E, Ganther HE, Medina D. Methylseleninic acid, a potent growth inhibitor of synchronized mouse mammary epithelial tumor cells in vitro. Biochem Pharmacol. 2001 Feb 1;61(3):311-7.
42. Sinha R, Medina D. Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. Carcinogenesis. 1997 Aug;18(8):1541-7.
43. Sinha R, Said TK, Medina D. Organic and inorganic selenium compounds inhibit mouse
    mammary cell growth in vitro by different cellular pathways. Cancer Lett. 1996 Oct
    22;107(2):277-84.
44. Spallholz JE. Selenium and the prevention of cancer. Part II: mechanism for the carcinostatic activity of Se compounds. Bull Selenium-Tellurium Dev Assoc. 2001 Oct;11(2):1-12.
45. Stewart MS, Spallholz JE, Neldner KH, Pence BC. Selenium compounds have disparate
    abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med. 1999
    Jan;26(1-2):42-8.
46. Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med. 1994 Jul;17(1):45-64.
47. Schrauzer GN, White DA, McGinness JE, Schneider CJ, Bell LJ. Arsenic and cancer: effects of joint administration of arsenite and selenite on the genesis of mammary adenocarcinoma in inbred female C3H/St mice. Bioinorg Chem. 1978 Sep;9(3):245-53.
48. Ip C, Ganther H. Efficacy of trimethylselenonium versus selenite in cancer chemoprevention and its modulation by arsenite. Carcinogenesis. 1988 Aug;9(8):1481-4.
49. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet
    Assoc. 1996 Oct;96(10):1027-39.
50. Walaszek Z, Szemraj J, Hanausek M, Adams JK, Sherman U. D-glucaric acid content of
    various fruits and vegetables and cholesterol-lowering effects of dietary calcium D glucarate in the rat. Nutr Res. 1996;16(4):673-81.
51. Fahey JW, Zalcmann AT, Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry. 2001 Jan;56(1):5-51.
52. Stoewsand GS. Bioactive organosulfur phytochemicals in Brassica oleracea vegetables –
    a review. Food Chem Toxicol. 1995 Jun;33(6):537-43.
53. Yang CS, Chhabra SK, Hong JY, Smith TJ. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic. J Nutr. 2001 Mar;131(3s):1041S-5S.
54. Whanger PD. Selenocompounds in plants and their effects on animals. In Cheeke PR (ed). Toxicants of Plant Origin. Volume III. Proteins and Amino Acids. 1989;Boca Raton, FL:CRC Press, 141-67. Cited by (57).
55. Schubert A, Holden JM, Wolf WR. Selenium content of a core group of foods based on a critical evaluation of published analytical data. J Am Diet Assoc. 1987 Mar;87(3):285 99.
56. Shi B, Spallholz JE. Selenium from beef is highly bioavailable as assessed by liver glutathione peroxidase (EC 1.11.1.9) activity and tissue selenium. Br J Nutr. 1994
    Dec;72(6):873-81.
57. Whanger PD. Selenocompounds in plants and animals and their biological significance. J
    Am Coll Nutr. 2002 Jun;21(3):223-32.
58. Ip C, Birringer M, Block E, Kotrebai M, Tyson JF, Uden PC, Lisk DJ. Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. J Agric Food Chem. 2000 Jun;48(6):2062-70.
59. Ip C, Lisk DJ. Efficacy of cancer prevention by high-selenium garlic is primarily dependent on the action of selenium. Carcinogenesis. 1995 Nov;16(11):2649-52.
60. Ip C, Lisk DJ. Characterization of tissue selenium profiles and anticarcinogenic responses in rats fed natural sources of selenium-rich products. Carcinogenesis. 1994 Apr;15(4):573-6.
61. Ip C, Lisk DJ, Stoewsand GS. Mammary cancer prevention by regular garlic and
    selenium-enriched garlic. Nutr Cancer. 1992;17(3):279-86.
62. Whanger PD, Ip C, Polan CE, Uden PC, Welbaum G. Tumorigenesis, metabolism,
    speciation, bioavailability, and tissue deposition of selenium in selenium-enriched ramps
    (Allium tricoccum). J Agric Food Chem. 2000 Nov;48(11):5723-30.
63. Vonderheide AP, Wrobel K, Kannamkumarath SS, B’Hymer C, Montes-Bayon M, Ponce De Leon C, Caruso JA. Characterization of Selenium Species in Brazil Nuts by HPLC-ICP-MS and ES-MS. J Agric Food Chem. 2002 Sep 25;50(20):5722-8.
64. Yeo JK, Cha SD, Cho CH, Kim SP, Cho JW, Baek WK, Suh MH, Kwon TK, Park JW, Suh SI. Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells. Cancer Lett. 2002 Aug 8;182(1):83-92.
65. Personal communication, Dr. Julian Spallholz, Texas Tech University Health Sciences Center.

PAGE 1 | PAGE 2 | PAGE 3 | PAGE 4 - REFERENCES

For more information on Selenium, please click below.
Selenium Article 1, Selenium Article 2, Selenium Article 3